期刊文献+

调控血脑屏障ABC转运体信号转导通路的研究现状 被引量:7

Study status of signaling pathways that regulate ABC transporter activity at the blood-brain-barrier
原文传递
导出
摘要 血脑屏障中的ABC转运体是介导内源性物质、药物和毒物转运的一类外排转运体,主要包括P-糖蛋白(P-gp)、多药耐药相关蛋白(Mrp)以及乳腺癌耐药蛋白(Bcrp)。这类转运体能限制外来异物进入中枢神经系统,使得很多治疗药物难以透过血脑屏障产生治疗作用,阐明这些转运蛋白的转运机制,可为药物的中枢转运提供新的靶点,有助于降低脑部耐药的发生,改善药物治疗的结局。本文主要针对ABC转运体以及涉及的肿瘤坏死因子-α/蛋白激酶C-β/鞘氨醇1磷酸酯受体1(TNF-α/PKCβ/S1PR1)信号通路、血管内皮生长因子信号通路和雌激素受体信号通路进行探讨。 ATP-binding cassette ( ABC ) transporters at blood-brain barrier, such as, P-glycoprotein ( P -gp ) , multidrug -resistance -associated protein ( Mrp ) , and breast cancer related protein ( Bcrp ) , can limit central nervous system ( CNS ) uptake of foreign chemicals, drugs and toxicant.ABC transporters are neuroprotective, but they also distinguish poorly between neurotoxicants and therapeutic drugs.So they are major obstacles to CNS pharmacotherapy.Clarifying the mechanisms of these transporters can provide new targets for drugs to get through the blood-brain barrier, which helps to reduce the occurrence of drug re-sistance and improve the effect of treatment.The present review is fo-cused on new findings about ABC transporters and three main signal path-ways, whose are TNF-α/PKCβ/S1PR1 signaling, vascular endothelial growth factor signaling and estrogen signaling.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2014年第11期1057-1059,共3页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金资助项目(81102877)
关键词 血脑屏障 ABC转运体 信号通路 blood brain barrier ATP -binding cassette transporter signal pathway
  • 相关文献

参考文献11

  • 1Abbott N J, Patabendige AAK, Dolman DEM, et al. Structure and function of the blood - brain barrier[ J]. Neurobiol Dis, 2010, 37 : 13 - 25.
  • 2Zlokovic BV. The blood - brain barrier in health and chronic neuro- degenerative disorders[J]. Neuron, 2008, 57:178-201.
  • 3Dominguez A, 61varez A, Hilario E, et al. Central nervous system diseases and the role of the blood - brain barrier in their treatment [ J]. Neurosci Discov, 2013, 1 : 3.
  • 4Miller DS. Regulation of P - glycopmtein and other ABC drug trans- porters at the blood - brain barrier [ J ]. Trends Pharmacol Sci, 2010, 31:246-254.
  • 5Robey RW, Masse), PR, Amiri - Kordestani L, et al. ABC trans- porters: unvalidated therapeutic targets in cancer and the CNS [ J ]. Anticancer Agents Med Chem, 2010, 10 : 625 - 633.
  • 6Chen QX, Hu HH, Zhou Q, et al. An overview of ABC and SLC drug transporter gene regulation[J]. Curr Drug Metab, 2013, 14: 253 - 264.
  • 7Porteous CM, Menon DK, Aigbirhio FI, et al. P - glycoprotein (Mdrla/lb) and breast cancer resistance protein (Bcrp) decrease the uptake of hydrophobic alkyl tfiphenylphosphonium cations by the brain( J ]. Biochim Biophys Acta, 2013, 1830 : 3458 - 3465.
  • 8Miller DS, Cannon RE. Signaling pathways that regulate basal ABC transporter activity at the blood -brain barrier [ J ]. Curt Pharm Des, 2013,20 : 1463 - 1471.
  • 9Hawkins BT, Sykes DB, Miller DS. Rapid, reversible modulation of blood - brain barrier P - plycoprotein transport activity by vascular endothelial growth gactor[J]. J Neurosci, 2010, 30: 1417-1425.
  • 10Hartz AM, Madole EK, Miller DS, et al. Estrogen receptor I~ sig- naling through phosphatase and tensin homolog/phosphoinositide 3 - kinase/Akt/glycogen synthase kinase 3 down - regulates blood - brain barrier breast cancer resistance protein[ J ]. J Pharmacol Exp Ther, 2010, 334:467 -476.

同被引文献77

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部